2006
DOI: 10.2337/dc06-0282
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Syndrome

Abstract: OBJECTIVE -Little is known about the prevalence of the metabolic syndrome among elderly people in Italy, its association with all-cause mortality, and whether measurement of serum C-reactive protein (CRP) and interleukin (IL)-6 affects this association.RESEARCH DESIGN AND METHODS -The baseline prevalence of metabolic syndrome, diagnosed according to the National Cholesterol Education Program (NCEP) criteria, and all-cause mortality at 4 years were recorded in an Italian population-based cohort (981 subjects, 5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
42
2
13

Year Published

2007
2007
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(61 citation statements)
references
References 23 publications
4
42
2
13
Order By: Relevance
“…Results from studies in elderly populations are more conflicting, with reports of no [16,22,25] and a slightly increased [17,23,26] risk of total mortality. Similarly, for CVD mortality, one study [16] found no increased risk, whereas others [17-21, 23, 25] have reported a slightly increased risk.…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…Results from studies in elderly populations are more conflicting, with reports of no [16,22,25] and a slightly increased [17,23,26] risk of total mortality. Similarly, for CVD mortality, one study [16] found no increased risk, whereas others [17-21, 23, 25] have reported a slightly increased risk.…”
Section: Discussionmentioning
confidence: 85%
“…It is therefore a challenge that much of the data on the association between metabolic syndrome and mortality comes from samples consisting predominantly of younger and middle-aged individuals [2][3][4][8][9][10][11][12][13][14][15], while few studies have presented age-stratified analyses. Across the studies that have addressed this association in older cohorts, increased mortality risk has not been a consistent finding [16][17][18][19][20][21][22][23][24][25][26]. We therefore examined the relationship between metabolic syndrome and both subsequent cardiovascular and total mortality in individuals who were stratified into three groups by age (40-59, 60-74 and 75-89 years).…”
Section: Introductionmentioning
confidence: 99%
“…Esta sín-drome tem impactos significativos a vários níveis, já que é notória a relação entre a SM e as doenças cardiovasculares implicadas com a morte precoce (15,21,30) . Além disso, a sua prevalência afecta diferentes estratos etários, sendo elevada tanto em adultos (36,43) , quanto em crianças e adolescentes (10,20,40,49,53) . Estes números reforçam a necessidade de tomar medidas urgentes direccionadas à prevenção e tratamento destas doenças assim como a redução dos seus factores de risco.…”
Section: Quintounclassified
“…Estudos que utilizaram os critérios recomendados pelo National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III), e adotados pela I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica (I-DBSM) [6], encontraram valores de prevalência variando de 28,1% a 43,5% em idosos norte-americanos [11,12], de 11,3 a 34,3% entre idosos europeus [13][14][15][16] e de 24 a 30,5% em asiáticos [17,18]. Seguindo esses mesmos critérios, estudos com idosos brasileiros têm apresentado índices de prevalência de SM que variam de 45,2 a 51,6%, sendo essa prevalência significativamente maior entre as mulheres (45,6 a 73,5% versus 26,5 a 44,4% nos homens) [10,19,20].…”
Section: Introductionunclassified